Serum Institute of India (SII) has informed the government that it will be able to manufacture and supply nine to 10 crore doses of Covishield in June, official sources said on Sunday amid complaint by States about the shortage of anti-coronavirus vaccine jabs. In a recent letter to Union Home Minister Amit Shah, SII said its employees have been working round the clock in spite of various challenges because of the pandemic. "Serum Institute of India has always been sincerely concerned about the protection of the citizens of our country and world at large from COVID-19. In early May, SII had communicated to the Centre that production of Covishield would be ramped up to 6.5 crore in June, seven crore in July and 10 crore each in August and September. India is currently using made-in-India vaccines — Covishield manufactured by SII and Covaxin of Bharat Biotech — in its COVID-19 immunisation programme.

Source: The Hindu May 30, 2021 12:10 UTC